|
HS Code |
662232 |
| Product Name | 4-Bromo-1,3-Benzodioxazole |
| Cas Number | 57060-64-7 |
| Molecular Formula | C7H4BrNO2 |
| Molecular Weight | 214.02 |
| Appearance | White to off-white solid |
| Melting Point | 98-102 °C |
| Purity | Typically ≥98% |
| Synonyms | 4-Bromo-1,3-benzodioxazole; 4-Bromobenzodioxazole |
| Chemical Class | Benzodioxazoles |
| Solubility | Soluble in organic solvents (e.g., DMSO, dichloromethane) |
| Smiles | Brc1ccc2OCOc2n1 |
| Inchi | InChI=1S/C7H4BrNO2/c8-4-1-2-5-6(3-4)11-7(10)9-5/h1-3H |
As an accredited 4-Bromo-1,3-Benzodioxazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-1,3-Benzodioxazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
4-Bromo-1,3-benzodioxazole stands out in the landscape of organic synthesis. Chemists have long sought compounds that deliver efficiency and predictability, both qualities that this derivative brings to the table. Boasting a bromo group at the fourth position of a benzodioxazole ring, this molecule opens doors that pure benzodioxazole or its unsubstituted cousins simply can’t. My own time in industrial labs has shown me that unique substitution patterns often make the difference between a convoluted synthesis and one that's scalable.
The structure draws attention right away: a benzene backbone fused to a dioxazole ring, with a bromine atom locked at position four. The simplicity on paper belies a toolkit for reactivity in practice. There’s something almost elegant in the way the electron-rich aromatic ring interacts with the electron-withdrawing bromo group. This specific model, C7H4BrO2, with molecular weight around 215.02 g/mol, checks all the boxes for a functional intermediate—stable enough to ship across continents, yet reactive enough to build more complex molecules. In the world of pharmaceutical and agrochemical research, few things matter more than stability during storage and transport, especially when regulations around safety and purity grow tighter each year.
In research labs and factories alike, chemists pursue bigger yields, easier routes, and molecules no one’s made before. 4-Bromo-1,3-benzodioxazole has taken on real importance as a precursor in making bioactive compounds. The bromine atom works almost like a handle, inviting cross-coupling reactions, particularly Suzuki and Buchwald–Hartwig couplings. I recall a medicinal chemistry campaign aiming for novel kinase inhibitors: using this bromo-substituted heterocycle helped our team rapidly diversify candidate structures. Traditional benzodioxazoles without the halogen didn’t respond to our chemistry toolkit quite so well.
What stands out is not just where this molecule fits in, but how it streamlines a portfolio of syntheses. Instead of long, multi-step preparations from simpler aromatics, 4-bromo-1,3-benzodioxazole often cuts out difficult protection-deprotection steps. Chemists trained in organic synthesis will notice fewer purification headaches—fewer co-eluting impurities, less loss on silica columns, and a cleaner pathway to analog libraries.
Beyond labs, I’ve seen industry chemists select this specific bromo-benzodioxazole when building out scaffolds for crop protection agents and even specialty polymers. The reactivity of the bromo group can be harnessed for direct installation of amino, aryl, or heterocyclic moieties, all of which influence the biological or physical properties of the resulting compounds.
Many might ask: why not just use 1,3-benzodioxazole, the parent skeleton, or other halogen derivatives? From firsthand experience, the presence, identity, and location of a halogen radically changes what’s possible. The fourth position lends selectivity—reactions proceed more predictably, and byproducts drop out at lower rates compared to isomers halogenated elsewhere. Chlorinated or iodinated benzodioxazoles don’t offer the same balance between cost, reactivity, and stability. Iodine’s bulk slows reactions, while chloride substitution often forces harsher conditions for cross-coupling.
Working on aromatic substitution chemistry, the clean, controlled reactivity of the bromo substituent at this position removes much of the guesswork. Chemists need predictability under scale-up conditions: reactor fouling, side-product formation, and inconsistent conversions all increase costs and risks. 4-Bromo-1,3-benzodioxazole consistently outperforms less-substituted versions or other halogens on those counts.
Specifications for this compound usually land in tight ranges. High-purity samples above 98% by HPLC or GC are now standard for pharmaceutical work. In the labs I’ve managed, we've seen suppliers respond to industry demands by providing consistent melting points in the range of 80–84°C, with well-documented spectral data. Today, reputable suppliers deliver with certificates of analysis tailored to major regulatory frameworks, making it easier to satisfy the increasing scrutiny of regulatory filings.
Effective purification of 4-Bromo-1,3-benzodioxazole, compared to similar molecules, relies less on repeated chromatography. Most modern producers now use crystallization or controlled crystallization methods that deliver solid product with low residual solvent and minimal inorganic contamination. Any process that reduces purification steps appeals to both environmental and economic interests—two factors that hold more sway now than ever.
For synthetic chemists, using 4-bromo-1,3-benzodioxazole feels less like an exercise in risk management and more like a reliable step forward. In large-scale production, time and again, it behaves reliably across temperature swings and minor process deviations. There's an obvious reason contract manufacturers favor it for the earliest steps of combinatorial synthesis and library generation.
In my own experience with library synthesis for pharmaceutical lead optimization, this molecule marches through Suzuki cross-coupling and nucleophilic aromatic substitution reactions. Even after hundreds of examples, yields remain robust. Each analog with a different side chain offers a real chance for new biological activity, not just a minor tweak. No two drug development projects look alike, but those that incorporate bromo-substituted intermediates often move faster through early-stage development.
A few years ago, a colleague’s work on fluorescent imaging agents put 4-bromo-1,3-benzodioxazole to the test. Its reactivity enabled rapid coupling with various heterocycles—an essential step for probe diversification. The bromo group handled a wide variety of reagents, even under high-throughput conditions that often trip up less stable cores.
On the plant science side, new herbicidal candidates often draw on benzodioxazole frameworks. Patents published over the last decade repeatedly list brominated analogues as stepping stones to active ingredients. This isn’t coincidence—reactivity, ease of purification, and regulatory familiarity all feed into R&D decisions.
Not every chemistry project demands a substituted heterocycle, and cost pressures are real. Yet, using non-halogenated or differently substituted compounds inevitably brings compromises. In practice, reactions with unsubstituted benzodioxazoles require harsher conditions, resulting in lower selectivity and more waste. Isomers with halogen at other positions can give rise to stubborn byproducts or unwanted isomerization, complicating scale-up.
Comparing 4-bromo-1,3-benzodioxazole to its 6-bromo cousin, selectivity often leans in favor of the fourth position, especially for cross-coupling. Chemists value predictability—it speeds up method development and minimizes regulatory headaches as one moves toward pilot production.
From a supply chain perspective, sources for the fourth-position bromo derivative now outnumber those for certain isomers, reflecting both demand and advances in synthetic methodology. The compound’s physical stability during shipping and storage reduces risk for producers and end-users alike. Now that environmental restrictions on solvent use, waste generation, and energy consumption have intensified, molecules that tolerate shorter, greener processes matter more than ever.
Safety has taken on greater urgency now that chemical regulations in North America, Europe, and Asia routinely scrutinize both intermediates and finished products. My teams have always emphasized rigorous risk assessment—even a stable molecule warrants respect. 4-Bromo-1,3-benzodioxazole brings a manageable hazard profile relative to more reactive halogenated aromatics. It won’t break down unpredictably in the bottle, and common lab ventilation protocols afford adequate control.
Disposal and environmental responsibility remain key concerns. The chemical's resilience means less reactive off-gassing compared to some fluoro or chloro analogues, cutting down both downtimes for fume hoods and costly waste remediation. Many process chemists I know favor routes that keep halogen content predictable and minimize extraneous steps, in which this compound excels.
Researchers investigating green chemistry routes point toward bromo-based cross-couplings that run at ambient temperature or in aqueous solvent, reducing resource consumption. If a compound lends itself to newer, less polluting methods—a feature routinely demonstrated by 4-Bromo-1,3-benzodioxazole—it provides tangible environmental and cost benefits.
No intermediate exists in a vacuum. Supply chain interruptions, fluctuating bromine prices, and regulatory changes all bear on the widespread utility of 4-bromo-1,3-benzodioxazole. Chemical manufacturers must attend not just to process yield, but to lifecycle impacts—sourcing bromine responsibly, mitigating by-product formation, and tracking emissions. In labs where budgets run tight, the cost of highly purified intermediates remains a concern.
From my years working with procurement and regulatory teams, forward-thinking suppliers distinguish themselves with clear provenance documentation—not only purity and performance data, but also answers to questions about upstream processes, waste handling, and human health. There's no shortcut around transparent record-keeping and honest dialogue between producer and user.
On the technical side, supporting the development of public-domain synthetic methods keeps costs lower and know-how accessible. Open publication of efficient, green reactions using 4-bromo-1,3-benzodioxazole lowers the barrier for small labs and startups, all while supporting more sustainable practices. Supporting academic-industry partnerships to improve access to both the compound and knowledge around it drives progress.
Digitalization and automation now touch every corner of chemical manufacturing. Laboratories using digital process controls often find improved throughput and quality tracking in the preparation of bromo-substituted heterocycles. Embedding real-time monitoring allows for rapid troubleshooting and higher first-pass success rates, further lowering the costs and risks tied to intermediates like this one.
The chemical sector keeps evolving. What worked in the early days of industrial chemistry passes muster less often now—precision, traceability, and sustainability matter every bit as much as reactivity. From what I’ve seen, 4-bromo-1,3-benzodioxazole walks the line well. Labs value it for the space it frees up in synthetic planning, the reliability it introduces to scale-up, and the options it creates for safer, more effective routes.
The compound’s impact cuts across fields. In drug and crop protection R&D, it can slash weeks off timelines. Polymer chemists use it to introduce functional groups that shape thermal or mechanical properties. Its shelf life ensures fewer scrapped batches and lower waste disposal costs. As research funding demands precise reporting and traceable sourcing, compounds with well-characterized supply chains and documented performance keep their edge.
Facing the future, chemists and business leaders alike weigh every input—environmental rules, technological advances, even consumer expectations. 4-Bromo-1,3-benzodioxazole earns a favored spot not solely by its molecular formula, but by supporting a new standard of thoughtful, responsible production.
The bar keeps rising. Compounds that support efficient synthesis, traceable supply, and lower environmental impact shape who gets ahead and who stagnates. Every measure I’ve seen suggests that 4-bromo-1,3-benzodioxazole stakes a claim among those forward-looking intermediates that balance cost, reactivity, and responsibility—the factors that matter in tomorrow’s chemical industry.